Merging St. Luke’s downgraded amid worsening reserve levels

St. Luke’s Duluth (Minn.) saw its long-term rating on a series of bonds lowered to “BB+” from “BBB-” amid weaker balance sheet metrics, S&P Global said Oct. 5.

Advertisement

Lower-than-expected operating performance contributed to the downgrade, according to the note.

“The rating action reflects our view of St. Luke’s deterioration in unrestricted reserves, weakening already-light balance sheet metrics to levels no longer commensurate with an investment-grade rating,” said S&P Global Ratings credit analyst Concy Richards.

St. Luke’s is planning to merge with Wausau, Wis.-based Aspirus Health to form a 19-hospital system, a proposed deal that is facing extra scrutiny from Minnesota Attorney General Keith Ellison.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.